Lithium neuroprotection: molecular mechanisms and clinical implications.
about
Pharmacometabolomic signature of ataxia SCA1 mouse model and lithium effectsTherapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorderAltered regulation of Akt signaling with murine cerebral malaria, effects on long-term neuro-cognitive function, restoration with lithium treatmentPotential role of purinergic signaling in lithium-induced nephrogenic diabetes insipidusLithium ameliorates phenotypic deficits in a mouse model of fragile X syndrome.A systematic review of existing data on long-term lithium therapy: neuroprotective or neurotoxic?Involvment of cytosolic and mitochondrial GSK-3beta in mitochondrial dysfunction and neuronal cell death of MPTP/MPP-treated neuronsLithium chloride regulates the proliferation of stem-like cells in retinoblastoma cell lines: a potential role for the canonical Wnt signaling pathway.The psychopathology and treatment of bipolar disorder.A genetic network model of cellular responses to lithium treatment and cocaine abuse in bipolar disorder.Lithium: a promising treatment for fragile X syndrome.A new avenue for lithium: intervention in traumatic brain injury.Lithium modifies brain arachidonic and docosahexaenoic metabolism in rat lipopolysaccharide model of neuroinflammation.Chemical inducers of autophagy that enhance the clearance of mutant proteins in neurodegenerative diseases.Dose-dependent protective effect of lithium chloride on retinal ganglion cells is interrelated with an upregulated intraretinal BDNF after optic nerve transection in adult rats.Is phosphoadenosine phosphate phosphatase a target of lithium's therapeutic effect?Using lithium as a neuroprotective agent in patients with cancerGSK-3 as a Target for Lithium-Induced Neuroprotection Against Excitotoxicity in Neuronal Cultures and Animal Models of Ischemic Stroke.Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disordersNeuroprotective action of lithium in disorders of the central nervous system.Combined treatment with the mood stabilizers lithium and valproate produces multiple beneficial effects in transgenic mouse models of Huntington's disease.Targeting renal purinergic signalling for the treatment of lithium-induced nephrogenic diabetes insipidus.Lithium prevents long-term neural and behavioral pathology induced by early alcohol exposureSize and shape of the caudate nucleus in individuals with bipolar affective disorder.GSK-3 is a viable potential target for therapeutic intervention in bipolar disorder.A genome-wide association study of bipolar disorder with comorbid eating disorder replicates the SOX2-OT regionThe expanding role of BDNF: a therapeutic target for Alzheimer's disease?Lithium inhibits Smad3/4 transactivation via increased CREB activity induced by enhanced PKA and AKT signaling.Effects of lithium and deafferentation on expression of glycogen synthase kinase-3beta, NFkappaB, beta-catenin and pCreb in the chick cochlear nucleus.Lithium: a versatile tool for understanding renal physiology.Enhanced lithium-induced brain recovery following cranial irradiation is not impeded by inflammation.Chronic administration of valproic acid reduces brain NMDA signaling via arachidonic acid in unanesthetized rats.Effects of mood stabilizers on DNA damage in an animal model of mania.Functional MRI of delayed chronic lithium treatment in rat focal cerebral ischemia.Estradiol and lithium chloride specifically alter NMDA receptor subunit NR1 mRNA and excitotoxicity in primary culturesLigand-activated peroxisome proliferator-activated receptor β/δ modulates human endometrial cancer cell survival.Effects of lithium chloride on the gene expression profiles in Drosophila heads.A putative amino acid transporter of the solute carrier 6 family is upregulated by lithium and is required for resistance to lithium toxicity in DrosophilaModulation of TLR2 protein expression by miR-105 in human oral keratinocytesP2Y(2) receptors and water transport in the kidney.
P2860
Q21559578-64801B8E-70C3-4403-9AD0-2E61EA29D248Q24626017-7CBE1B6E-15DA-443C-8C54-5BC6FE5D9227Q28484464-6DE48DE4-45FC-4815-AF23-0FC6F477DF72Q28583651-ABF026B5-9060-4989-A8B5-1FDFE0456C24Q30500501-7278E845-C4B1-48E9-A387-312280A43CC5Q33284843-B68322C8-B73E-445C-BA7E-DF56D5B21B85Q33442821-CD24D09F-12B6-474B-9130-2E0B28376D5EQ33523529-4A9EE800-36CE-4B22-B313-2AA755902355Q33619910-0A9E132B-F5DF-4C47-A0AB-AB172163B562Q33751814-3749B65D-149F-42B0-95AD-D5778006F122Q33777951-14BEE314-09AB-4827-A428-031AFC6A9F28Q33777980-0A64D2A5-DB69-42DC-B7D9-681147A3C9B3Q33784486-D390ED69-35F3-421A-97A1-B0BFBA0751A4Q33799555-C41731CD-A744-414F-8BDA-94F022984875Q34158396-36133615-202F-4D27-A19D-7655DF2FBDF3Q34253497-AC6D2DD9-3C08-480E-9ACA-35FD687ACBEBQ34465844-8F4F1C68-60E4-4191-9BBF-4DBDE567A547Q35154467-94AE3BF3-C9D5-4D30-A8C8-05EF85B83914Q35197096-46226BEA-C876-4A95-9049-9F16F028DD7CQ35212429-B3649EDC-7B92-48FF-9561-AC4F9E7F2826Q35356604-7124C980-9E5C-4062-A2E3-2DAC91ED2689Q35602671-05AE4DB2-144B-4B40-AD00-7A73BDB199D7Q35803113-072E0E7B-0182-4327-AA7A-51B0D6E1D32CQ35894870-0002BFA5-01BD-4E7C-BCFF-383B62E654BEQ36062876-22E8377C-AD53-4A49-8580-B1ED97FE6998Q36268966-64119699-0AD9-439F-B2CE-EA21D1A04949Q36325596-789FB4BF-648F-401B-864E-1A88AE792E49Q36513464-FFFAAE20-359C-4601-B3BE-2E6568D234B7Q36645701-7A97C84F-B0F9-4A83-A45D-642B4D8C66B6Q36836247-2F9D09FF-510A-427C-912D-1D2B88AA61DAQ36861598-65AD72C2-8F7B-4AA4-9D15-A042E978318FQ36930683-A3136B0E-84BC-4F30-969D-861CE4CA2E6FQ36955638-80065F4C-1895-48CC-BE73-4E53D4904DF4Q37017501-60772A8A-EF6F-4E36-97F5-C06357F2686AQ37189865-8BB08AE8-3A10-4EE7-9BA9-04A47281C7F4Q37296865-9D8B4F7A-EDE3-422C-B821-F40D68B61C02Q37344654-D5DC2CB6-5906-4F62-B8DE-BDACE14DFF77Q37353450-4BC9BD49-7DC8-4266-B835-BC647FE7350AQ37371743-97532B11-EC4C-44A9-9DF0-948A90C4E7DFQ37418657-CC9D8AAD-0860-4B31-A485-542F002CD88B
P2860
Lithium neuroprotection: molecular mechanisms and clinical implications.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Lithium neuroprotection: molecular mechanisms and clinical implications.
@ast
Lithium neuroprotection: molecular mechanisms and clinical implications.
@en
type
label
Lithium neuroprotection: molecular mechanisms and clinical implications.
@ast
Lithium neuroprotection: molecular mechanisms and clinical implications.
@en
prefLabel
Lithium neuroprotection: molecular mechanisms and clinical implications.
@ast
Lithium neuroprotection: molecular mechanisms and clinical implications.
@en
P1476
Lithium neuroprotection: molecular mechanisms and clinical implications.
@en
P2093
De-Maw Chuang
Michael K Rowe
P356
10.1017/S1462399404008385
P577
2004-10-18T00:00:00Z